Invention Grant
- Patent Title: Gram-positive bacteria specific binding compounds
-
Application No.: US14103715Application Date: 2013-12-11
-
Publication No.: US09266943B2Publication Date: 2016-02-23
- Inventor: Tim Beaumont , Mark Jeroen Kwakkenbos , Eric J. Brown , John Hiroshi Morisaki , Wouter L. W. Hazenbos , Sanjeev Mariathasan , Kimberly Kajihara , Yi Xia
- Applicant: Genentech, Inc. , AIMM THERAPEUTICS B.V.
- Applicant Address: US CA South San Francisco NL Amsterdam
- Assignee: Genentech, Inc.,AIMM Therapeutics B.V.
- Current Assignee: Genentech, Inc.,AIMM Therapeutics B.V.
- Current Assignee Address: US CA South San Francisco NL Amsterdam
- Agency: Morrison & Foerster LLP
- Priority: EP09165558 20090715
- Main IPC: A61K39/40
- IPC: A61K39/40 ; C07K16/12
Abstract:
The present invention provides improved binding compounds capable of specifically binding Gram-positive bacteria. Binding compounds are provided that are fully human, enabling therapeutic applications in human individuals.
Public/Granted literature
- US20140235828A1 GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS Public/Granted day:2014-08-21
Information query
